VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 560 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2015. The put-call ratio across all filers is 2.18 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $277,000 | -56.1% | 10,502 | +69.0% | 0.10% | -58.1% |
| Q4 2015 | $631,000 | +44.4% | 6,214 | +153.4% | 0.24% | +42.2% |
| Q3 2015 | $437,000 | -36.8% | 2,452 | -21.1% | 0.17% | -30.8% |
| Q2 2015 | $691,000 | +11.6% | 3,108 | -0.3% | 0.24% | +10.1% |
| Q1 2015 | $619,000 | +24.5% | 3,118 | -10.2% | 0.22% | +17.8% |
| Q4 2014 | $497,000 | -15.6% | 3,473 | -22.7% | 0.18% | -18.9% |
| Q3 2014 | $589,000 | -56.4% | 4,490 | -58.1% | 0.23% | -54.9% |
| Q2 2014 | $1,352,000 | +18.2% | 10,717 | +23.5% | 0.50% | +7.2% |
| Q1 2014 | $1,144,000 | +9.4% | 8,681 | -2.6% | 0.47% | +3.5% |
| Q4 2013 | $1,046,000 | +15.1% | 8,910 | +2.4% | 0.46% | +3.9% |
| Q3 2013 | $909,000 | +5.8% | 8,705 | -12.8% | 0.44% | +15.0% |
| Q2 2013 | $859,000 | – | 9,979 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |